Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

IDH Mutations and Trisomy 8 In Myelodysplastic Syndromes and Acute Myeloid Leukemia

Domenica Caramazza, Terra Lasho, MT, (ASCP), Christy Finke, Naseema Gangat, David Dingli, M.D., Ph.D., Ryan Knudson, Sergio Siragusa, MD, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Rhett Ketterling, Ayalew Tefferi, MD

Blood (2010) 116 (21): 4009.

https://doi.org/10.1182/blood.V116.21.4009.4009

Published: 2010

Journal Articles

LNK Mutation Studies In Chronic- and Blast-Phase Myeloproliferative Neoplasms and JAK2 Mutation-Negative Erythrocytosis

Terra Lasho, MT, (ASCP), Ayalew Tefferi, MD, Alessandro M. Vannucchi, MD, Christy Finke, Paola Guglielmelli, MD, Lisa Pieri, MD, Animesh Pardanani, MBBS, PhD

Blood (2010) 116 (21): 4105.

https://doi.org/10.1182/blood.V116.21.4105.4105

Published: 2010

Journal Articles

Characterization of BMS-911543, a Functionally Selective Small Molecule Inhibitor of JAK2

Ashok V Purandare, PhD, Animesh Pardanani, MBBS, PhD, Theresa McDevitt, Marco Gottardis, PhD, Terra Lasho, MT, (ASCP), Dan You, Louis Lombardo, Becky Penhallow, Ragini Vuppugalla, George Trainor, PhD, Ayalew Tefferi, MD, Matthew Lorenzi, PhD

Blood (2010) 116 (21): 4112.

https://doi.org/10.1182/blood.V116.21.4112.4112

Published: 2010

Journal Articles

A Phase I/II Study of CYT387, An Oral JAK-1/2 Inhibitor, In Myelofibrosis: Significant Response Rates In Anemia, Splenomegaly, and Constitutional Symptoms

Animesh Pardanani, MBBS, PhD, Geeta George, P.A.-C, Terra Lasho, MT, (ASCP), William J. Hogan, MBBCH, BA, MRCPI, Mark R. Litzow, MD, Kebede Begna, MD, Curtis A. Hanson, MD, Rose Fida, Chris Burns, Gregg D Smith, Ayalew Tefferi, MD

Blood (2010) 116 (21): 460.

https://doi.org/10.1182/blood.V116.21.460.460

Published: 2010

Journal Articles

Circulating IL-2R, IL-8, IL-15 and CXCL10 Levels Are Independently Prognostic In Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

Rakhee Vaidya, Domenica Caramazza, Christy Finke, Terra Lasho, MT, (ASCP), Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2010) 116 (21): 3068.

https://doi.org/10.1182/blood.V116.21.3068.3068

Published: 2010

Journal Articles

Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms

Omar Abdel-Wahab, Animesh Pardanani, MBBS, PhD, Jay Patel, Terra Lasho, MT, (ASCP), Adriana Heguy, Ross Levine, MD, Ayalew Tefferi, MD

Blood (2010) 116 (21): 3070.

https://doi.org/10.1182/blood.V116.21.3070.3070

Published: 2010

NARROW

IDH Mutations and Trisomy 8 In Myelodysplastic Syndromes and Acute Myeloid Leukemia

LNK Mutation Studies In Chronic- and Blast-Phase Myeloproliferative Neoplasms and JAK2 Mutation-Negative Erythrocytosis

Characterization of BMS-911543, a Functionally Selective Small Molecule Inhibitor of JAK2

A Phase I/II Study of CYT387, An Oral JAK-1/2 Inhibitor, In Myelofibrosis: Significant Response Rates In Anemia, Splenomegaly, and Constitutional Symptoms

Circulating IL-2R, IL-8, IL-15 and CXCL10 Levels Are Independently Prognostic In Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

IDH Mutations and Trisomy 8 In Myelodysplastic Syndromes and Acute Myeloid Leukemia

LNK Mutation Studies In Chronic- and Blast-Phase Myeloproliferative Neoplasms and JAK2 Mutation-Negative Erythrocytosis

Characterization of BMS-911543, a Functionally Selective Small Molecule Inhibitor of JAK2

A Phase I/II Study of CYT387, An Oral JAK-1/2 Inhibitor, In Myelofibrosis: Significant Response Rates In Anemia, Splenomegaly, and Constitutional Symptoms

Circulating IL-2R, IL-8, IL-15 and CXCL10 Levels Are Independently Prognostic In Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only